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Purpose: To establish the validity of intracerebral hemorrhage (ICH) diagnoses in the 
Danish Stroke Registry (DSR) and the Danish National Patient Registry (DNPR).
Patients and Methods: Based on discharge summaries and brain imaging reports, we 
estimated the positive predictive value (PPV) of a first-ever diagnosis code for ICH (ICD-10, 
code I61) for all patients in the Region of Southern Denmark (1.2 million) during 2009–2017 
according to either DNPR or DSR. We estimated PPVs for any non-traumatic ICH (a-ICH) 
and spontaneous ICH (s-ICH) alone (ie, without underlying structural cause). We also 
calculated the sensitivity of these diagnoses in each of the registers. Finally, we classified 
the location of verified s-ICH.
Results: A total of 3,956 patients with ICH diagnosis codes were studied (DSR only: 87; 
DNPR only: 1,513; both registries: 2,356). In the DSR, the PPVs were 86.5% (95% CI=85.1– 
87.8) for a-ICH and 81.8% (95% CI=80.2–83.3) for s-ICH. The PPVs in DNPR (discharge 
code, primary diagnostic position) were 76.2% (95% CI=74.7–77.6) for a-ICH and 70.2% 
(95% CI=68.6–71.8) for s-ICH. Sensitivity for a-ICH and s-ICH was 76.4% (95% CI=74.8– 
78.0) and 78.7% (95% CI=77.1–80.2) in DSR, and 87.3% (95% CI=86.0–88.5) and 87.7% 
(95% CI=86.3–88.9) in DNPR. The location of verified s-ICH was lobar (39%), deep (33.6%), 
infratentorial (13.2%), large unclassifiable (11%), isolated intraventricular (1.9%), or unclas-
sifiable due to insufficient information (1.3%).
Conclusion: The validity of a-ICH diagnoses is high in both registries. For s-ICH, PPV was 
higher in DSR, while sensitivity was higher in DNPR. The location of s-ICH was similar to 
distributions seen in other populations.
Keywords: stroke, intracerebral hemorrhage, epidemiology, validity, register-based research
Introduction
Administrative registries that routinely collect data at a population level can be useful 
resources for studies of temporal trends in cerebrovascular disorders,1–5 and in obser-
vational research focusing on the cause, treatment, and course of stroke.6–20 Large 
clinical databases or medical registers anchored in well-defined populations can 
furthermore be a particularly attractive solution to the challenge of acquiring valid 
data over extended time-periods for relatively rare disorders such as intracerebral 
hemorrhage (ICH).10,21–29 However, to be useful data sources for epidemiologic 
research, registers must first provide data of sufficiently high quality. While validity 
is important for all types of research based on register information, for studies of trends 
in the incidence of diseases, knowledge of the degree of sensitivity of the data is also 
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paramount.30,31 In Denmark, two nationwide registers are of 
particular use for identifying patients with stroke for research 
purposes: the Danish Stroke Registry (DSR) and the Danish 
National Patient Registry (DNPR). The sensitivity of ICH 
diagnoses in these registers is unknown, and to date only a 
few studies have examined the validity of ICH diagnoses in 
DSR32 or DNPR.33–36 Supplementary Table S1 summarizes 
the existing studies.
We conducted this study with the purpose to provide 
estimates of the validity of ICH diagnoses in DSR and 
DNPR and to acquire data on the location of ICH in a 
large unselected sample of patients with a spontaneous 
parenchymal hemorrhage.
Patients and Methods
We defined any non-traumatic ICH (a-ICH) as a sympto-
matic event (new headache, altered level of consciousness, 
or neurological symptoms), with or without new neurolo-
gical signs, referable to a focal collection of blood within 
the brain parenchyma seen on brain imaging with signal 
characteristics consistent with the time of symptom onset. 
We defined spontaneous ICH (s-ICH), as ICH not attribu-
table to prior trauma, hemorrhagic transformation of an 
ischemic stroke, or an alternative explanation (eg, tumor or 
vascular malformation – but not use of antithrombotic 
drugs).32,37 The above definition is similar to the World 
Health Organization (WHO) stroke definition,38 but in 
addition allows inclusion of patients based on symptoms 
(eg, severe sudden onset headache), where imaging sup-
ports new onset ICH.
Setting and Data Sources
We based this study on data from hospital contacts of 
residents of the Region of Southern Denmark (RSD; 1.2 
million inhabitants), a geographically defined region in 
Denmark. Patients suspected of a stroke are principally 
admitted or transferred to one of the four dedicated stroke 
units at neurology departments in the region, which also 
hosts a single neurosurgery department.32 All hospitals in 
Denmark report data in a standardized format to the 
DNPR.39
The Danish Stroke Registry (DSR), a clinical database, 
was established in Denmark in 2003 to monitor the quality 
of care provided to stroke patients. It is mandatory to 
report standardized detailed information on all acute 
admissions for stroke at hospitals in Denmark to the 
DSR.40,41
The regional authorities have copies of all hospital 
electronic medical records (EMRs) in RSD, which can be 
used for research purposes, provided consent is obtained 
from the heads of departments involved in patient care.32
We identified all hospital contacts of residents of RSD 
recorded in DNPR (data since 2007 made available to us) 
or DSR (data since 2003, when the register became opera-
tional). In DNPR, for the period January 1, 2007 to 
December 31, 2017 we retrieved information on any hos-
pital contacts (ie, inpatient, outpatient, or emergency 
department contacts) with International Classification of 
Diseases version 10 (ICD-10) I61 (intracerebral hemor-
rhage) as the principal diagnostic code (in Danish, 
“aktionsdiagnose”) or in any other diagnostic position. In 
DSR, stroke diagnoses are recorded as “hemorrhagic 
stroke” (ie, ICH), “ischemic stroke”, or “unspecified”. 
We retrieved data on all hospital contacts recorded under 
“hemorrhagic stroke” in DSR for the period January 1, 
2003 to December 31, 2017 using the same residency 
criteria as above. Within each register sample, we limited 
records to each patient’s first hospital contact within the 
years 2009–2017, a period where medical records and 
brain imaging reports were more likely to be available. 
We focused on first-ever ICH and therefore excluded 
patients with records of ICH (DNPR inpatient, outpatient 
or ED – any diagnostic position, or DSR) predating the 
study period (ie, before January 1, 2009).
Identification of Cases for Validation
We designed this study similar to a previous validation 
study we performed in the same region for a shorter time- 
period (2010–2015) and based on a smaller sample of 
patients with ICH (n=500 patients).32 Motivated by our 
previous results,32 and aiming to identify reliable algo-
rithms that would enable optimal use of the register data, 
we designed the present validation study to calculate PPV 
of the DSR and DNPR when used independently, or in 
combination. The researchers that performed the assess-
ments described below were blinded with regard to the 
register source.
We identified information on patients with a possible 
first-ever diagnosis of ICH as follows. We retrieved data 
on all patients recorded under ICH diagnoses in the 
DNPR, or the DSR in 2009–2017, as described above.
To minimize capture of re-admissions for the same 
ICH event, we identified the first hospital contact during 
the period. Furthermore, we only included patients that 
were aged 20+ years at the time of the first hospital contact 
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as DSR only records data on adult patients. We merged the 
resulting data and classified patients into three mutually 
exclusive groups: i) recorded in both registries, ii) 
recorded in DNPR only; and iii) recorded in DSR only. 
We only classified patients as recorded in both registries if 
hospital contact dates in the two registries were separated 
by no more than 7 days, in order to enhance the likelihood 
of studying the same event.
For patients identified in the DNPR, in addition to the 
contact on the index date, we also identified all other 
hospital contacts (ie, admission, outpatient, or emergency 
department (ED)) with a diagnosis code of ICH that we 
considered to belong to the same episode of ICH, ie, 
consecutive contacts separated by a gap of no more than 
7 days. Based on this information, we classified patients 
recorded by DNPR by patterns of contact as follows: a) 
inpatient with ICH discharge code in primary diagnostic 
position (regardless of ED/outpatient contacts); b) inpati-
ent with ICH discharge code in diagnostic position other 
than primary (regardless of ED/outpatient contacts); or c) 
outpatient only or ED only, any diagnostic position.
Data on all patients, identified as outlined above, were 
validated based on information from discharge records and 
brain scan reports. These documents were mainly (63%) 
provided to us in electronic form by the regional autho-
rities, which hold copies of all hospital EMRs in RSD. All 
hospitals in RSD use the same EMR system that was 
gradually implemented in the years 2008–2015. For con-
tacts with no record in the centralized copy of EMRs 
(mainly records predating the introduction of the EMR 
system), we requested manually retrieved copies of dis-
charge summaries and brain scan reports from the hospital 
departments involved. We were granted permission to 
retrieve data as outlined by all heads of departments 
involved. In anticipation of the logistic difficulties 
involved, we did not retrieve information on patients 
residing in RSD who were only recorded with ICH diag-
noses at hospitals located out of the region or abroad (<2% 
of cases).
Based on previous experience,32 to ensure coverage of 
transfers between units (eg, from ED to stroke unit, or 
from one hospital to another), and of further work-up for 
secondary causes (eg, follow-up imaging after incident 
ICH), we requested discharge records and brain imaging 
study reports for a period spanning 1 week before to 5 
months after the hospital contact date of the index event. 
Nine study physicians – supervised by two neurologists 
and a specialist in radiology with a special interest in 
stroke – assessed this information and abstracted data to 
a structured form. Information collected included ICH 
diagnosis verified, whether it was s-ICH, and the location 
of s-ICH.
We classified ICH into “single ICH” or “multiple ICH” 
(more than one concurrent ICH described in brain scan 
report). We classified ICH location based on a slightly 
modified version of the criteria employed in a previous 
population-based study:37 1) “deep ICH” (single supraten-
torial deep ICH, or multiple ICHs in solely deep loca-
tions); 2) “infratentorial ICH” (single infratentorial ICH, 
or multiple ICHs in solely infratentorial locations, or infra-
tentorial ICH combined with deep ICH); 3) “large unclas-
sifiable ICH”; 4) “isolated intraventricular ICH”; 5) 
“insufficient information to classify”; and 6) “lobar ICH” 
(all other, ie, ICH locations not included in cate-
gories 1–5).
Full medical records were retrieved in cases of doubt 
regarding the diagnosis.
Study data were collected and managed using REDCap 
electronic data capture tools hosted at Odense Patient data 
Explorative Network (OPEN).42,43
Statistical Analyses
We computed PPVs of registry diagnoses of ICH for each 
of the sources (DNPR vs DSR), and for each of the three 
groups (ie, DNPR & DSR, DNPR only, or DSR only), as 
proportions of each parameter confirmed by the verifica-
tion process described above. We computed the sensitivity 
of the registers when used as independent sources (ie, 
either DNPR or DSR) as the proportion of number of 
cases verified by each source divided by the total number 
of cases verified in either of the registers. We used the 
Wilson score method to estimate 95% confidence intervals 
for all proportions.44 We also calculated a chi-square sta-
tistic for the trend45 (regression) of sensitivity estimates 
across the three time periods (2009–2011; 2012–2014; 
2015–2017) and age-groups (<65; 65–74; ≥75 years).
All analyses were performed using Stata 16.1 (Stata 
Corp, TX).
The study was approved by the Danish Data Protection 
Agency (Approval ID 18/51966) and the Danish Health 
and Medicines Authority (Approval ID 3–3013-942/1).
Results
A total of 2,590 and 4,176 discharges were recorded under 
ICH diagnosis codes in DSR and DNPR, respectively. 
Cross-linkage of the data from the two registries resulted 
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in 4,149 patients, after exclusion of patients younger than 
20 years (n=52), and patients who only had been registered 
with ICH diagnoses at hospitals outside the region (n=78). 
Exclusion of a further 193 patients, where we could not 
obtain the medical records, resulted in a total study popu-
lation of 3,956 patients (Figure 1). In all, 59.6% were 
recorded in both registries, 2.2% in DSR only, and 
38.3% in DNPR only. The percentage of untraced medical 
record information in the three categories was 4.5% for 
DSR & DNPR, 7.5% (n=7) for DSR only, and 4.7% for 
DNPR only.
For patients included in the study, we retrieved both 
discharge letters and brain scan reports in 93%, discharge 
letters only in 1%, and brain scan reports only in 6% of 
cases. In a few cases (n=94), the discharge letter and/or 
brain scan report were deemed insufficient to reach a 
diagnosis, in which case we retrieved full medical records 
or re-evaluated original brain scans.
The diagnosis of a-ICH could not be verified in a total 
of 1,192 cases (30.1%). Close to half of the patients in this 
group (n=528) had suffered an ICH that did not fulfill 
study criteria (eg, ICH due to trauma), and another third 
of patients had intracranial hemorrhages other than ICH 
(n=396) (Table 1). The corresponding percentages by reg-
istry source (ie, DSR/DNPR inpatient, primary coding 
position) were a) ICH that did not fulfill study criteria 
(56.7%/45.8%); and b) intracranial hemorrhage other 
than ICH (35.4%/23.3%).
Among patients with verified a-ICH (n=2,764), an 
underlying cause was found in 225 patients (most fre-
quently (92%) hemorrhages in brain tumors, or from arter-
iovenous malformations or cavernous hemangiomas 
(Table 1)), leaving a total of 2,539 patients with s-ICH.
We compared the earliest date of contact with a code of 
ICH according to registry data (registry date) with the date 
of onset of ICH as assessed by the study physician who 
evaluated the retrieved medical record information. For 
cases with verified a-ICH, the onset date was within 7 
days of the registry date in 93% of cases (the two dates 
were identical in 82% of cases), while it differed by more 
than a week in 2.6% of cases only; information on date of 
onset could not be accurately established based on medical 
record information in 4.3% of cases, mostly due to vague 
wording (eg, “symptoms for a few days with subacute ICH 
changes on brain scan” with no mention of the exact date 
of onset).
For the majority of patients with a-ICH, the initial scan 
was a computed tomography (CT) of the brain (CTC) 
(94%), while for 4% of patients the initial scan was CT- 
angiography (CTA), or brain magnetic resonance imaging 
Figure 1 Identification of patient records for validation from the DSR and DNPR.
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(MRI) (1.2%). In 0.8% of a-ICH patients the type of brain 
scan was unknown as the brain scan report was not traced 
and the discharge letter, although referring to the brain 
imaging result, did not specify the type of scan performed. 
Initial brain scan reports of patients with a-ICH frequently 
described intraventricular spread of the hematoma (37%), 
a known poor prognostic sign, and signs indicative of 
increased intracranial pressure (deviation of midline struc-
tures 32%, presence of hydrocephalus 10%, hernia-
tion 3.2%).
Among patients with s-ICH, further imaging work-up 
was performed in 49.5% of cases (n=1,256); in 24% of 
cases in the form of brain MRI, CTA, or both. The per-
centage of patients with s-ICH that had been further inves-
tigated with imaging was higher in younger patients (age 
≤55 years: 64%; age 56+years: 48%).
Our definition of ICH differed slightly from the WHO 
definition, in that we also included patients with non-focal 
symptoms or symptoms lasting less than 24 hours if brain 
imaging revealed acute parenchymal hemorrhage. Cases 
verified according to our criteria would also have been 
classified as such according to WHO criteria in 96.7% of 
cases for a-ICH and 96.4% of cases for s-ICH.
Positive Predictive Values of ICH 
Diagnosis Code
In DSR, the PPV for a-ICH diagnosis was 86.5% (95% 
CI=85.1–87.8) and for s-ICH 81.8% (95% CI=80.2–83.3). 
The corresponding values for DNPR were higher for inpa-
tient codes with ICH in the primary diagnostic position, 
compared with inpatient codes with ICH in the coding posi-
tion other than primary for both a-ICH (76.2%; 95% 
CI=74.7–77.6 vs 49.5%; 95% CI=45.6–53.4) and s-ICH 
(70.2%; 95% CI=68.6–71.8 vs 43.7%; 95% CI=39.9–47.6) 
(Table 2). In analyses where we combined data from the two 
sources, the highest PPV was observed among patients con-
currently recorded in DSR and DNPR–inpatient primary 
diagnostic position (a-ICH: 88.6%; 95% CI=87.1–89.9 and 
s-ICH: 83.7%; 95% CI=82.1–85.2) and the lowest PPV 
among patients only recorded in DNPR with ICH codes for 
outpatient or ED contacts (7.4%; 95% CI=3.2–16.1 for both 
a-ICH and s-ICH) (Table 3). Year of admission, age, and sex 
had little impact on PPV of a-ICH and s-ICH in DSR or 
DNPR–inpatient primary diagnostic position (Table 4).
Sensitivity of ICH Diagnosis Code
The sensitivity in DSR for a-ICH was 76.4% (95% 
CI=74.8–78.0) and for s-ICH 78.7% (95% CI=77.1– 
80.2); for DNPR–inpatient primary diagnostic position 
the sensitivity for a-ICH was 87.3% (95% CI=86.0–88.5) 
and for s-ICH 87.7% (95% CI=86.3–88.9). The sensitivity 
Table 1 Underlying Diagnoses in Non-Verified Cases and in 
Verified Cases Not Classified as Spontaneous ICH
Non-Verified Cases Number 
(%) 
(n=1,192)
ICH present, but did not fulfill study criteria 515 (43.2)
ICH, traumatic 268
Acute ischemic stroke with hemorrhagic 
transformation
123
ICH, thrombolysis-related 53
ICH due to subarachnoid hemorrhage 24
ICH, periprocedurala 21
ICH suspected, but patient died before scan 18
History of ICH (predating study period) 8
Intracranial hemorrhage other than ICH 396 (33.2)
Subarachnoid hemorrhageb 205
Subdural hematoma 152
Traumatic intracranial hemorrhage, multiple sites 21
History of intracranial hemorrhage 10
Epidural hematoma 8
Ischemic and other cerebrovascular diagnoses 115 (9.7)
Acute ischemic stroke 99
TIA 8
Other cerebrovascular disordersc 8
Various 166 (13.9)
ICH or intracranial bleed suspected; ruled out by 
brain scan
41
Cerebral microbleedsd 13
Seizure 11
Headache, syncope, or vertigo 11
Cerebral tumor 9
Various coding errorse 81
Verified cases with non-spontaneous 
ICH,funderlying cause
Number 
(%) 
(n=225)
Brain tumor 105 (46.7)
Arteriovenous malformation 61 (27.1)
Cavernous hemangioma 41 (18.2)
Cerebral sinus thrombosis 7 (3.1)
Dural arteriovenous fistula 6 (2.7)
Various rare causesg 5 (2.2)
Notes: aeg, ventricular catheter insertion. bNumber of patients with aneurysmal/ 
traumatic/unspecified: 110/57/38. ceg, transient global amnesia, cerebral sinus 
thrombosis. dNo coexisting ICH or any other intracranial hemorrhage. e1-2 patients 
recorded per code under these primarily (>70%) non-neurological codes. fClassified 
as “any ICH” but not “spontaneous ICH”. gNot specified to preserve anonymity. 
Abbreviation: ICH, intracerebral hemorrhage.
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in DSR declined over time for both a-ICH and s-ICH (eg, 
s-ICH: 2009–2011: 85.6%, 95% CI=83.0–87.9 vs 
2012–2014: 78.2%; 95% CI=75.2–80.9% vs 2015–2017: 
73.3%; 95% CI=70.4–76.0). Sensitivity in DSR was 
higher in older patients for both a-ICH and s-ICH (eg, 
s-ICH: <64 years: 74.5%; 95% CI=71.1–77.7 vs 65–74 
years: 79.2%; 95% CI=76.0–82.1 vs 75+ years 80.6%; 
95% CI=78.3–82.7) (Table 4). When stratified across 
both age (<75 years vs ≥75 years) and sex strata, sensitiv-
ity remained high for DNPR; for DSR, sensitivity esti-
mates were highest for men aged 75+ years (91% in 
2009–2011; 80% in 2012–2014; 82% in 2015–2017) and 
lowest for women younger than 75 years (82% in 
2009–2011; 72% in 2012–2014; 64% in 2015–2017), the 
overall pattern being compatible with a decline in sensi-
tivity over time across all strata (Table 5).
Table 2 Positive Predictive Value of Admission Codes for ICH in Danish National Patient Registry (DNPR) and Danish Stroke Registry 
(DSR)
No. Retrieved No. Verified PPV (95% CI)
Any ICH Spontaneous ICH Any ICH Spontaneous ICH
DNPR – inpatient diagnosis
Primary diagnostic positiona 3,169 2,414 2,226 76.2 (74.7–77.6) 70.2 (68.6–71.8)
Other than primary diagnostic positionb 632 312 276 49.4 (45.5–53.3) 43.7 (39.9–47.6)
Any diagnostic positionc 3,801 2,726 2,502 71.7 (70.3–73.1) 65.8 (64.3–67.3)
DSR 2,443 2,113 1,998 86.5 (85.1–87.8) 81.8 (80.2–83.3)
Notes: aIncludes 2,116 patients concurrently recorded in DSR. bIncludes 240 patients concurrently recorded in DSR. cIncludes 2,356 patients concurrently recorded in 
DNPR. 
Abbreviations: ICH, intracerebral hemorrhage; PPV, positive predictive value.
Table 3 Number of Patients Identified and Number of Verified Diagnoses of ICH by Type of Contact in Danish National Patient 
Registry (DNPR) and by Concurrent Recording in Danish Stroke Registry (DSR)
Patients with First-Ever Hospital Contact with Intracerebral Hemorrhage Codes, Region of Southern Denmark 2009–2017 
(n=3,956)
DNPR DSR Onlyb DNPRa or 
DSR
Inpatient, Primary Diagnostic 
Position
Inpatient, Diagnostic Position 
Other Than Primary
Outpatient/ 
ED Only,b 
Any Diagnostic 
Position
Record in 
DSRc
No Record in 
DSRd
Record in 
DSRc
No Record in 
DSRd
Number retrieved 2116 1053 240 392 68 87 3956
Any-ICH diagnosis 
confirmed
Number 1874 540 206 106 5 33 2764
PPV (95% CI) 88.6  
(87.1–89.9)
51.3  
(48.3–54.3)
85.8  
(80.9–89.7)
27.0  
(22.9–31.6)
7.4  
(3.2–16.1)
37.9  
(28.5–48.4)
69.9  
(68.4–71.3)
Spontaneous-ICH 
confirmed
Number 1771 455 195 81 5 32 2539
PPV (95% CI) 83.7  
(82.1–85.2)
43.2  
(40.2–46.2)
81.3  
(75.8–85.7)
20.7  
(16.9–24.9)
7.4  
(3.2–16.1)
36.8  
(27.4–47.3)
64.2  
(62.7–65.7)
Notes: We regarded consecutive hospital contacts coded for ICH and with a gap of no more than 7 days as belonging to the same episode of ICH. aDNPR inpatient, 
outpatient, or ED – any position. bNo concurrent inpatient record in DNPR. cConcurrent record in DSR. dNo concurrent record in DSR. 
Abbreviations: ED, emergency department; ICH, intracerebral hemorrhage; PPV, positive predictive value.
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Patients with Untraceable Medical 
Records
We excluded 193 patients with untraceable medical 
records (untraced cases) from the above analyses. The 
proportion of untraced cases declined during the study 
period (2009–2011: 116 [60%]; 2012–2014: 57 [30%]; 
2015–2017: 20 [10%]) (Table 6). The proportion of 
untraced cases among inpatients in DSR and DNPR also 
varied by time period, while similar in analyses by age and 
sex (Table 7). The majority of untraced cases before 2015 
had received ICH diagnosis codes as inpatients and were 
recorded in both DSR and DNPR, while in the last 3-year 
part of the study period, the small number of untraced 
cases primarily comprised hospital contacts other than 
inpatients (Table 7). The higher number of untraced 
cases before 2015 was primarily due to paper-based med-
ical records (ie, predating the EMR system) no longer 
being available in the archives of some hospitals in the 
catchment area.
Location of s-ICH
Among the 2,539 cases of s-ICH, 2,430 had a single ICH 
and 109 multiple concurrent ICH (Table 8). The location 
of the hemorrhage in s-ICH (single or multiple) was lobar 
(39.0%), deep (33.6%), infratentorial (13.2%), large 
unclassifiable (11.0%), or isolated intraventricular hemor-
rhage (1.9%); we could not classify the location in 1.3% of 
s-ICH due to insufficient information (1.2% of single ICH 
and 4.6% of multiple ICH cases).
Discussion
In this large study with data from an entire Danish region for 
the years 2009–2017, we found a high validity of a-ICH 
diagnosis in DSR and DNPR–inpatient primary coding 
Table 4 PPV and Sensitivity of Inpatient First-Ever Codes for ICH in the Danish Stroke Registry and the Danish National Patient 
Registry Stratified by Year, Age, and Sex
Any ICH Danish National Patient Registrya Danish Stroke Registry
PPV (95% CI) Sensitivity (95% CI) PPV (95% CI) Sensitivity (95% CI)
Periodb
2009–2011 74.0 (71.2–76.6) 86.7 (84.2–88.8) 86.6 (84.1–88.8) 83.7 (81.1–86.1)
2012–2014 76.7 (74.1–79.2) 90.0 (87.8–91.8) 86.6 (84.1–88.8) 75.9 (73.0–78.6)
2015–2017 77.5 (75.0–79.9) 85.6 (83.3–87.6) 86.3 (83.8–88.4) 70.7 (67.9–73.4)
Ageb (years)
<64 74.9 (72.0–77.6) 87.9 (85.4–90.0) 88.2 (85.4–90.6) 70.3 (66.9–73.4)
65–74 79.2 (76.2–81.9) 87.5 (84.8–89.7) 87.7 (84.9–90.0) 77.5 (74.3–80.4)
75+ 75.3 (73.1–77.5) 86.9 (85.0–88.7) 84.9 (82.8–86.9) 79.4 (77.1–81.6)
Sex
Men 77.7 (75.6–79.6) 87.4 (85.6–89.1) 87.6 (85.6–89.3) 77.7 (75.5–79.8)
Women 74.6 (72.4–76.7) 87.2 (85.3–88.9) 85.3 (83.2–87.2) 74.9 (72.6–77.2)
Spontaneous ICH
Periodc
2009–2011 69.8 (66.9–72.6) 87.3 (84.8–89.4) 82.8 (80.1–85.3) 85.6 (83.0–87.9)
2012–2014 69.2 (66.4–72.0) 90.6 (88.4–92.5) 79.9 (76.9–82.5) 78.2 (75.2–80.9)
2015–2017 71.6 (68.9–74.1) 85.4 (83.1–87.6) 82.6 (79.8–85.0) 73.3 (70.4–76.0)
Agec (years)
<64 63.8 (60.6–66.9) 88.2 (85.5–90.4) 79.4 (76.0–82.4) 74.5 (71.1–77.7)
65–74 74.0 (70.9–77.0) 88.4 (85.7–90.6) 82.8 (79.7–85.6) 79.2 (76.0–82.1)
75+ 72.1 (69.8–74.4) 87.0 (86.3–88.8) 82.4 (80.2–84.5) 80.6 (78.3–82.7)
Sex
Men 71.8 (69.6–74.0) 87.7 (85.8–89.3) 82.9 (80.7–84.9) 79.8 (77.6–81.9)
Women 68.6 (66.3–70.9) 87.7 (85.7–89.4) 80.6 (78.2–82.7) 77.5 (75.1–79.7)
Notes: aInpatient – primary diagnostic position code. bChi-squared for trend: P>0.05. cChi-squared for trend: P<0.001. 
Abbreviations: CI, confidence interval; ICH, intracerebral hemorrhage; PPV, positive predictive value.
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position using each of these registries as a single data source. 
For s-ICH, validity was also high in DSR, but was lower in 
DNPR. PPVs of patients recorded in both registries were 
higher, compared with PPVs based on patients only recorded 
in one of the registries. The sensitivity of DNPR was higher 
than that of DSR, with the latter exhibiting some degree of 
variation by age of patients (ie, higher sensitivity in older 
patients) and time-period (ie, lower sensitivity in later com-
pared with earlier part of study period).
Four studies have reported data on the validity of ICH 
diagnoses in DNPR (Supplementary Table S1).32–34,36 
Studies predating year 2000 reported PPVs of 66%33 and 
74%,34 respectively, while a study36 concerning data from 
1993 to 2009 reported a PPV of 76%. Finally, a study32 by 
our group with data from the same region as the present study 
for the years 2010–2015 reported a PPV of 75% for s-ICH in 
DNPR. The reported PPVs from previous studies by other 
groups presumably also represent s-ICH, as stroke was 
defined according to WHO criteria in these studies (although 
only one study36 explicitly stated that traumatic ICH was 
excluded). We conclude that the PPV of 70% in this study, 
although somewhat lower, is in line with previous reports on 
the validity of s-ICH in DNPR. We report a PPV of 81% for 
s-ICH in DSR, which is similar to the result of our previous 
study (PPV 85%) in the same catchment area. We previously 
reported higher PPVs for a-ICH in both DNPR (88%) and 
DSR (94%), compared with the results of the present study 
(DNPR: 76%; DSR: 87%). In our previous study, we only 
studied a sample of patients with ICH diagnoses and only 
validated patients with available EMR records. This may 
have resulted in overrepresentation of patients treated at the 
university hospital in the catchment area, as this hospital had 
the largest patient volume and, in addition, was the first 
hospital in RSD to switch to the EMR system. We also note 
that our estimates of a-ICH in the present study would have 
been even higher, had we included certain cases of ICH that 
were excluded by design (eg, ICH due to trauma, hemorrha-
gic transformation, iatrogenic ICH).
We report novel data on the sensitivity of ICH diag-
noses in DSR and DNPR. As DSR is primarily based on 
Table 5 Sensitivity of Inpatient First-Ever Codes for ICH in the Danish Stroke Registry and the Danish National Patient Registry 
Stratified by Year, Age, and Sex
Danish National Patient Registrya
2009–2011 2012–2014 2015–2017 P-valueb
Any ICH
Women <75 years old 87.2 (81.7–91.3) 91.8 (86.8–94.9) 86.5 (81.4–90.3) >0.05
Women ≥75 years old 85.8 (80.7–89.8) 86.4 (81.5–90.2) 86.8 (82.2–90.3) >0.05
Men <75 years old 88.0 (83.7–91.3) 91.1 (87.2–93.8) 83.1 (78.5–86.8) >0.05
Men ≥75 years old 84.8 (78.2–89.6) 91.1 (86.0–94.5) 86.9 (81.6–90.8) >0.05
Spontaneous ICH
Women <75 years old 88.6 (82.9–92.6) 94.0 (89.0–96.8) 86.3 (80.8–90.4) >0.05
Women ≥75 years old 85.8 (80.6–89.8) 86.8 (81.8–90.5) 86.9 (82.2–90.5) >0.05
Men <75 years old 88.7 (84.4–92.0) 92.0 (88.0–94.8) 82.9 (78.1–86.8) 0.03
Men ≥75 years old 85.2 (78.4–90.1) 91.1 (85.8–94.5) 86.6 (81.2–90.6) >0.05
Danish Stroke Registry
Any ICH
Women <75 years old 81.9 (75.8–86.8) 72.0 (65.1–78.0) 64.2 (57.8–70.1) <0.001
Women ≥75 years old 85.4 (80.2–89.4) 79.0 (73.5–83.7) 69.5 (63.8–74.7) <0.001
Men <75 years old 80.9 (75.9–85.1) 74.2 (68.9–78.9) 70.3 (65.0–75.1) 0.029
Men ≥75 years old 89.4 (83.5–93.4) 78.3 (71.8–83.7) 80.6 (74.6–85.4) 0.046
Spontaneous ICH
Women <75 years old 85.0 (78.8–89.6) 76.0 (68.6–82.1) 68.5 (61.7–64.6) <0.001
Women ≥75 years old 86.3 (81.1–90.2) 79.5 (73.9–84.2) 71.0 (65.2–76.2) <0.001
Men <75 years old 82.7 (77.7–86.8) 77.2 (71.6–82.0) 72.7 (67.3–77.6) 0.005
Men ≥75 years old 90.8 (85.0–94.6) 79.8 (73.1–85.1) 81.6 (75.7–86.3) 0.035
Notes: aInpatient – primary diagnostic position code. bChi-squared for trend. 
Abbreviations: CI, confidence interval; ICH, intracerebral hemorrhage; PPV, positive predictive value.
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reporting from stroke units in Denmark, patients only 
admitted to non-stroke units could potentially be missed. 
Our results regarding sensitivity of DSR for s-ICH (79%) 
were therefore reassuring, although we did observe some 
variation in sensitivity over time and across age-groups. 
While the cause of this variation is unknown to us, these 
findings emphasize the need for periodic validation of the 
data. DNPR inpatient data with primary diagnostic posi-
tion codes are frequently used in Danish studies of cere-
brovascular disorders, as this approach is believed to result 
in outcomes with higher validity than data with broader 
criteria (eg, inclusion of inpatients regardless of diagnostic 
position of code).4,6,46–50 Our findings support this strategy 
with regard to s-ICH. We also note that the high sensitivity 
of s-ICH based on inpatient primary diagnostic position 
codes was stable in the 9-year study period and across age- 
groups.
The distribution of location of hemorrhage in patients 
with s-ICH was as expected from the literature.37,51,52 
However, we did not provide results regarding mixed- 
location ICH (ie, lobar and deep), as we excluded patients 
with a history of ICH; also, among the included patients 
we only had information on concurrent multiple ICHs at 
our disposal. When assessing for mixed-location ICH, a 
more appropriate method would have been to evaluate 
patients with sufficiently sensitive brain imaging studies 
(eg, MRI with SWI or T2* sequences) for signs of pre-
vious hemorrhage.53 However, in our study, such an 
approach would probably provide a low yield, as MRI 
with SWI/T2*, although available upon request at all 
hospitals throughout the study period, only became part 
of the routine ICH work-up late in the study period (after 
2015) and only in some of the hospitals in RSD (Nina 
Nguyen, consultant radiologist, personal communication).
Our study has some strengths. We used nationwide 
registries where simple and accurate cross-linkage was 
Table 6 Distribution of Patients with Untraceable Medical 
Records by Year and Contact Recorded in Danish National 
Patient Registry (DNPR) and/Or Danish Stroke Registry (DSR)
Period Number (%) of Patients All
DNPR Inpatient 
Contact 
and DSRa
Any Other 
Contactb
2009–2011 80 (73.4) 36 (26.6) 116
2012–2014 29 (54.7) 28 (45.3) 57
2015–2017 <5 NRc (>75%) 20
Notes: *Percentage not calculated for counts less than 5 to preserve anonymity. 
aConcurrently recorded in Danish National Patient Registry (DNPR) as inpatient 
(ICH code at any diagnostic position) and Danish Stroke Registry (DSR). 
bCorresponds to a) patients with records in DNPR (inpatient, emergency depart-
ment or outpatient), but no concurrent record in DSR; and b) patients with records 
in DSR only. cNot reported to preserve anonymity.
Table 7 Distribution of Patients with Untraceable Medical Records by Source, Year, Age, and Sex
Danish National Patient Registrya,b Danish Stroke Registryc
Inpatient, Primary Diagnostic 
Position
Inpatient, Diagnostic Position 
Other Than Primary
Retrieved, Including 
Untraced
Untraced,d 
No. (%)
Retrieved Including 
Untraced
Untraced,d 
No. (%)
Retrieved Including 
Untraced
Untraced,d 
No. (%)
Period
2009–2011 1093 100 (9.1) 600 9 (1.5) 1,810 84 (4.6)
2012–2014 1091 41 (3.8) 621 12 (1.9) 1,634 32 (2.0)
2015–2017 1145 19 (1.7) 738 0 (0) 1,680 <5 (NRe)
Age (years)
<64 941 40 (4.3) 564 8 (1.4) 1,272 24 (1.9)
65–74 826 33 (4.0) 525 <5 (–*) 1,318 24 (1.8)
75+ 1562 87 (5.6) 870 10 (1.1) 2,534 71 (2.8)
Sex
Men 1696 93 (5.5) 1,017 10 (1.0) 2,668 70 (2.6)
Women 1633 67 (4.1) 942 11 (1.2) 2,456 49 (2.0)
Notes: *Percentage not calculated for counts less than 5 to preserve anonymity. aDoes not include cases with ICH codes recorded in the Danish National Patient Registry 
with contacts classified as outpatient/emergency department contact only (retrieved/untraced: 73/5). bPatients concurrently recorded in Danish Stroke Registry included. 
cPatients concurrently recorded in Danish National Patient Registry included. dDischarge letter and brain scan report could not be traced, primarily due to incompleteness 
of archives for pre-EMR medical records at certain hospitals in the catchment area. eNot reported to preserve anonymity.
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facilitated by the unique and permanent civil registration 
number of residents of Denmark. The majority of previous 
studies (Supplementary Table S1) were based on relatively 
small samples of patients with ICH occurring among par-
ticipants in various cohort studies conducted in urban areas 
of Denmark.33,34,36 In two of these studies,33,36 patients 
diagnosed with stroke were on average younger than seen 
in recent population-based studies of stroke. In this study, 
we included all patients with ICH diagnosis codes seen at 
any hospital department according to two sources (DSR 
and DNPR) and regardless of type of hospital contact 
(inpatient, outpatient, or ED), or diagnostic code position 
in DNPR. By securing data for these potential cases of 
ICH in an entire region for a 9-year period we ensured a 
large sample diagnosed through standards corresponding 
to current clinical practice and in all probability represen-
tative of the whole spectrum of this frequently devastating 
disorder. Therefore, the results of this study are likely 
better with regard to generalizability as compared with 
previous studies. Studies based on Danish registries are 
frequently published in international peer-reviewed jour-
nals and therefore presumably have a large impact on 
research all over the world. The information provided by 
this manuscript can contribute to the correct interpretation 
of such register-based studies concerning ICH.
Our study has a number of limitations. First, we used 
discharge letters and brain scan reports to verify the diag-
noses, a previously validated method.32 It could be argued 
that a more optimal approach would have been to evaluate 
the entire medical record of each patient and re-evaluate 
the original brain imaging studies. We evaluated this more 
extensive and logistically challenging approach in a small 
sample of patients (n=100) in a previous study, and found 
it produced highly similar results to those achieved with 
the more limited data approach used in the present study, 
both with regard to a-ICH/s-ICH status and ICH location.-
32 Second, although we used multiple sources to identify 
all adult patients with ICH, it is likely that some patients 
were not captured by our hospital-based method. We did 
not identify patients with ICH that died before reaching 
hospital. As the rate of autopsy in Denmark is quite low,54 
supplementing our data with information from the Cause- 
of-Death Registry would most likely not improve our 
estimates to any measurable degree with regard to this 
source of bias. Our data sources did not include informa-
tion on patients suspected of suffering an ICH that were 
not referred to hospital for evaluation. However, in 
Denmark, patients suspected of stroke, regardless of age, 
are considered medical emergencies and are therefore 
almost invariably promptly referred/transferred to hospital 
for evaluation. Based on our clinical experience, we there-
fore believe that the magnitude of this selection bias is 
relatively small. Third, some patients with ICH may have 
been incorrectly coded under non-ICH diagnoses. Previous 
Danish studies reported a very low degree of misclassifi-
cation of ICH coded as other types of stroke or intracranial 
hemorrhage.6,12,32,55 Our calculation of sensitivity is based 
on the assumption that patients with true ICH would have 
an ICH code in at least one of the studied data sources. We 
do not know how often physicians diagnosing ICH acci-
dentally use non-cerebrovascular disorder codes but jud-
ging by data on the reverse situation in our study (ie, 
patients with other diagnoses coded as ICH), this scenario 
is rare. Fourth, our more inclusive approach with regard to 
diagnostic criteria is debatable. We used the WHO criteria 
for stroke, but in addition accepted inclusion of patients 
based on symptoms (eg, severe sudden onset headache), 
where imaging supported new onset ICH. Our more inclu-
sive approach could potentially hamper comparison with 
previous studies based exclusively on WHO criteria. 
However, as more than 96% of cases included in this 
study also fulfilled the WHO criteria, we believe that use 
of our criteria, while more accurately reflecting current 
clinical practice, had little impact on the comparability of 
Table 8 Location of Spontaneous Intracerebral Hemorrhage
Single ICH (n=2,430) Multiple ICH (n=109) All ICH (n=2,539)
Location Number % Number % Number %
Lobar 914 37.6 77 70.6 991 39.0
Deep 839 34.5 13 11.9 852 33.6
Infratentorial 321 13.2 14 12.8 335 13.2
Unclassifiable – large 279 11.5 0 0 279 11.0
Isolated intraventricular hemorrhage 48 2.0 NA NA 48 1.9
Insufficient information 29 1.2 5 4.6 34 1.3
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our results with those of previous studies. Our criteria also 
diverged from the original, strictly clinical WHO criteria 
in that we only included patients with available neuroima-
ging results. However, routine use of neuroimaging in 
cases suspected of stroke is widely available at all hospi-
tals in Denmark. Also, neuroimaging results made it pos-
sible to classify the location of ICH, a practice encouraged 
in updated criteria for population-based studies of ICH.56 
Fifth, the generalizability of our study results at a national 
level can be questioned, as we only included data from one 
of the five regions in Denmark. However, patients with 
stroke are treated in accordance to the national guidelines 
in all of Denmark57 and RSD is representative of the 
Danish population with regard to demographic character-
istics, healthcare utilization, and medication use.58 Finally, 
we excluded patients with untraced medical records, which 
may have influenced our estimates of validity of ICH 
coding. However, as patients from this group comprised 
less than 5% of the entire sample, and additional analyses 
made it most likely that PPV was high among untraced 
cases, we find it unlikely that this factor had other than a 
minor impact on our results.
Conclusion
In our study, based on all identifiable consecutive cases of 
first-time ever ICH in a defined Danish population – irre-
spective of clinical severity and mode of hospital contact – 
we found that the validity of a-ICH diagnoses was high in 
both DSR and DNPR. With regard to s-ICH, data in DSR 
were more valid, but less complete than DNPR data. Our 
results can provide guidance for the future use of these data 
sources for research (eg, cohort and case-control studies, 
time-series, before-and-after studies) of ICH and clinical 
practice (eg, audit purposes, evaluation of services).
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